Conmed (CNMD) Non-Current Deferred Tax Liability (2010 - 2026)

Conmed has reported Non-Current Deferred Tax Liability for 17 years, with the latest figure at $81.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 16.33% year-over-year to $81.4 million; the trailing twelve-month figure through Mar 2026 stood at $81.4 million (up 16.33% YoY), and the FY2025 full-year result was $79.5 million, down 55.11% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $81.4 million, up from $79.5 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $177.2 million in Q4 2024, with the low at $60.9 million in Q4 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $79.7 million across 5 years, with a median of $66.9 million in 2023.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability jumped 190.91% — and 2025, when it sank 55.11%.
• Conmed's Non-Current Deferred Tax Liability stood at $66.7 million in 2022, then dropped by 8.73% to $60.9 million in 2023, then soared by 190.91% to $177.2 million in 2024, then slumped by 55.11% to $79.5 million in 2025, then increased by 2.32% to $81.4 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $81.4 million (Q1 2026), $79.5 million (Q4 2025), and $74.9 million (Q3 2025), per Business Quant data.